Latest Safety News

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.

Macro Metals Limited has launched its second Indigenous joint venture, Robe River Kuruma Macro Mining, to foster sustainable mining and socio-economic benefits in the West Pilbara region.

Dynamic Metals has secured approval to commence an extensive Reverse Circulation drilling campaign at its Cognac West gold prospect, targeting high-grade anomalies identified in recent sampling. The program, set to begin in early 2025, aims to unlock significant gold mineralisation in Western Australia’s Widgiemooltha region.

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.

Vonex Limited has announced a $13.9 million non-renounceable entitlement offer to reduce its substantial debt, with major shareholder Maxo Telecommunications underwriting the raise. The move comes as CEO Ian Porter prepares to depart, marking a pivotal moment for the telecommunications provider.

Emyria reports sustained and statistically significant improvements in PTSD symptoms and quality of life three months after MDMA-assisted therapy, signaling a potential breakthrough for treatment-resistant patients.

Argenica Therapeutics has reported compelling preclinical data showing ARG-007 significantly reduces brain cell damage and inflammation in moderate traumatic brain injury, matching levels seen in uninjured controls. This reinforces ARG-007’s potential as a breakthrough neuroprotective therapy.

Vulcan Energy has begun mobilising its advanced V20 drilling rig to the Schleidberg site in Germany, marking a key milestone in its Phase One Lionheart Project to produce sustainable lithium for electric vehicle batteries.

Vonex Limited has announced a $13.9 million non-renounceable entitlement offer primarily aimed at reducing its debt, alongside the upcoming departure of CEO Ian Porter. Major shareholder MaxoTel is backing the raise with a substantial commitment.

Rapid Lithium Limited has closed its partially underwritten entitlement offer, raising $53,860 with 37 applications, and is now working to place the remaining shortfall by April 2025.

Noxopharm has successfully completed key in vitro safety tests for its SOF-SKN™ lupus drug, paving the way for the upcoming HERACLES Phase 1 clinical trial.

Philsaga Mining Corporation has announced a delay in the completion of its Tigerway decline at the Co-O Mine, citing COVID-19 disruptions and a significant earthquake as key factors. The company is now focusing on horizontal drives to improve ore transport and ventilation, with full decline completion expected by year-end 2025.